Bastide le Confort Medical (BLC) Stock Statistics & Valuation Metrics

Bastide le Confort Medical has a market cap or net worth of EUR 132.36M. The enterprise value is EUR 487.51M.

Market Cap

EUR 132.36M

Enterprise Value

EUR 487.51M

Bastide le Confort Medical has 7,365,078 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

7,365,078

Owned by Insiders

―

Owned by Institutions

0.48%

Bastide le Confort Medical’s return on equity (ROE) is 0.44 and return on invested capital (ROIC) is 6.94%.

Return on Equity (ROE)

0.44

Return on Assets (ROA)

0.10

Return on Invested Capital (ROIC)

6.94%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

132.49K

Profits Per Employee

15.96K

Employee Count

3,641

Asset Turnover

0.84

Inventory Turnover

11.29

The current PE Ratio of Bastide le Confort Medical is 2.31. Bastide le Confort Medical’s PEG ratio is 0.00.

PE Ratio

2.31

PS Ratio

0.28

PB Ratio

1.02

Price to FCF

4.33

Price to Operating Cash Flow

1.63

PEG Ratio

0.00

In the last 12 months, Bastide le Confort Medical had revenue of 482.39M and earned 58.10M in profits. Earnings per share was 7.89.

Revenue

482.39M

Gross Profit

50.87M

Operating Income

44.22M

Pretax Income

14.58M

Net Income

58.10M

EBITDA

104.85M

Earnings Per Share (EPS)

7.89

In the last 12 months, operating cash flow was 81.78M and capital expenditures -51.02M, giving a free cash flow of 30.77M billion.

Operating Cash Flow

81.78M

Free Cash Flow

30.77M

Free Cash Flow per Share

4.21

Bastide le Confort Medical pays an annual dividend of EUR 0.27, resulting in a dividend yield of ―

Dividend Per Share

EUR 0.27

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

23.08%

Earnings Yield

43.53%

Beta

0.56

52-Week Price Change

-26.15%

50-Day Moving Average

20.28

200-Day Moving Average

23.28

Relative Strength Index (RSI)

44.61

Average Volume (3m)

3,366

Bastide le Confort Medical upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 21, 2026

Next Earnings Date

Mar 24, 2027

Ex-Dividend Date

Jan 07, 2022

Bastide le Confort Medical as a current ratio of 1.20, with Debt / Equity ratio of 228.22%

Current Ratio

1.20

Quick Ratio

0.97

Debt to Market Cap

1.55

Net Debt to EBITDA

2.39

Interest Coverage Ratio

1.89

In the past 12 months, Bastide le Confort Medical has paid 4.58M in taxes.

Income Tax

4.58M

Effective Tax Rate

0.31

Bastide le Confort Medical EV to EBITDA ratio is 3.66, with an EV/FCF ratio of 12.49.

EV to Sales

0.80

EV to EBITDA

3.66

EV to Free Cash Flow

12.49

EV to Operating Cash Flow

4.70

Bastide le Confort Medical has EUR 48.21M in cash and marketable securities with EUR 299.13M in debt, giving a net cash position of -EUR 250.92M billion.

Cash & Marketable Securities

EUR 48.21M

Total Debt

EUR 299.13M

Net Cash

-EUR 250.92M

Net Cash Per Share

-EUR 34.07

Tangible Book Value Per Share

-EUR 7.41

Gross margin is 10.55%, with operating margin of 9.17%, and net profit margin of 12.04%.

Gross Margin

10.55%

Operating Margin

9.17%

Pretax Margin

3.02%

Net Profit Margin

12.04%

EBITDA Margin

21.74%

EBIT Margin

9.17%

The average price target for Bastide le Confort Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-1.79%

EPS Growth Forecast

10979.07%

Smart Score

―

AI Score

52